Your browser doesn't support javascript.
loading
High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer.
Shen, Yuqing; Lin, Hui; Chen, Kelie; Ge, Wanzhong; Xia, Dajing; Wu, Yihua; Lu, Weiguo.
Afiliação
  • Shen Y; Women's Reproductive Health Laboratory of Zhejiang Province, Women's Hospital School of Medicine Zhejiang University, Hangzhou, 310006, China.
  • Lin H; Department of Gynecologic Oncology of Women's Hospital School of Medicine Zhejiang University, Hangzhou, 310058, Zhejiang, China.
  • Chen K; Women's Reproductive Health Laboratory of Zhejiang Province, Women's Hospital School of Medicine Zhejiang University, Hangzhou, 310006, China.
  • Ge W; Department of Gynecologic Oncology of Women's Hospital School of Medicine Zhejiang University, Hangzhou, 310058, Zhejiang, China.
  • Xia D; Department of Toxicology of School of Public Health, and Department of Gynecologic Oncology of Women's Hospital School of Medicine Zhejiang University, Hangzhou, 310058, Zhejiang, China.
  • Wu Y; Division of Human Reproduction and Developmental Genetics, Women's Hospital School of Medicine Zhejiang University, Hangzhou, 310058, Zhejiang, China.
  • Lu W; Institute of Genetics and Department of Genetics School of Medicine Zhejiang University, Hangzhou, 310058, Zhejiang, China.
J Ovarian Res ; 15(1): 48, 2022 Apr 27.
Article em En | MEDLINE | ID: mdl-35477477

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cistadenocarcinoma Seroso Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cistadenocarcinoma Seroso Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article